FDA Brief

Company record

VITRUVIAS THERAPEUTICS INC

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about VITRUVIAS THERAPEUTICS INC.

Recalls

ReportedClassFirmProduct and reason
Sep 23 Class I VITRUVIAS THERAPEUTICS INC
Drug
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 696…
Superpotent Drug